KNOW LABS INC (KNW) Fundamental Analysis & Valuation

NYSEARCA:KNWUS4992382022

Current stock price

2.14 USD
+0.08 (+3.88%)
At close:
2.1191 USD
-0.02 (-0.98%)
After Hours:

This KNW fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. KNW Profitability Analysis

1.1 Basic Checks

  • KNW had negative earnings in the past year.
  • In the past year KNW has reported a negative cash flow from operations.
  • In the past 5 years KNW always reported negative net income.
  • KNW had a negative operating cash flow in each of the past 5 years.
KNW Yearly Net Income VS EBIT VS OCF VS FCFKNW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

  • KNW has a Return On Assets of -3181.63%. This is amonst the worse of the industry: KNW underperforms 99.47% of its industry peers.
Industry RankSector Rank
ROA -3181.63%
ROE N/A
ROIC N/A
ROA(3y)-196.65%
ROA(5y)N/A
ROE(3y)-930.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KNW Yearly ROA, ROE, ROICKNW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K -2K

1.3 Margins

  • KNW does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KNW Yearly Profit, Operating, Gross MarginsKNW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

0

2. KNW Health Analysis

2.1 Basic Checks

  • KNW has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for KNW is higher compared to a year ago.
KNW Yearly Shares OutstandingKNW Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
KNW Yearly Total Debt VS Total AssetsKNW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • KNW has an Altman-Z score of -407.69. This is a bad value and indicates that KNW is not financially healthy and even has some risk of bankruptcy.
  • KNW has a Altman-Z score of -407.69. This is amonst the worse of the industry: KNW underperforms 96.79% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -407.69
ROIC/WACCN/A
WACCN/A
KNW Yearly LT Debt VS Equity VS FCFKNW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

  • KNW has a Current Ratio of 0.03. This is a bad value and indicates that KNW is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.03, KNW is not doing good in the industry: 98.40% of the companies in the same industry are doing better.
  • KNW has a Quick Ratio of 0.03. This is a bad value and indicates that KNW is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.03, KNW is doing worse than 98.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
KNW Yearly Current Assets VS Current LiabilitesKNW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

1

3. KNW Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 42.83% over the past year.
  • KNW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)42.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.89%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • KNW is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.18% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25%
EPS Next 2Y8.56%
EPS Next 3Y1.18%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KNW Yearly Revenue VS EstimatesKNW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2026 2M 4M 6M
KNW Yearly EPS VS EstimatesKNW Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -5 -10 -15 -20

0

4. KNW Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KNW. In the last year negative earnings were reported.
  • Also next year KNW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KNW Price Earnings VS Forward Price EarningsKNW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KNW Per share dataKNW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.56%
EPS Next 3Y1.18%

0

5. KNW Dividend Analysis

5.1 Amount

  • No dividends for KNW!.
Industry RankSector Rank
Dividend Yield N/A

KNW Fundamentals: All Metrics, Ratios and Statistics

KNOW LABS INC

NYSEARCA:KNW (8/14/2025, 8:04:02 PM)

After market: 2.1191 -0.02 (-0.98%)

2.14

+0.08 (+3.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05
Earnings (Next)11-12
Inst Owners1.32%
Inst Owner Change33.5%
Ins Owners8.64%
Ins Owner Change0%
Market Cap844.17M
Revenue(TTM)N/A
Net Income(TTM)-15.67M
Analysts80
Price Target40.8 (1806.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.03
EYN/A
EPS(NY)-9.29
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3181.63%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-196.65%
ROA(5y)N/A
ROE(3y)-930.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z -407.69
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)144.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.89%
EPS Next Y25%
EPS Next 2Y8.56%
EPS Next 3Y1.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.63%
OCF growth 3YN/A
OCF growth 5YN/A

KNOW LABS INC / KNW Fundamental Analysis FAQ

What is the fundamental rating for KNW stock?

ChartMill assigns a fundamental rating of 0 / 10 to KNW.


What is the valuation status for KNW stock?

ChartMill assigns a valuation rating of 0 / 10 to KNOW LABS INC (KNW). This can be considered as Overvalued.


How profitable is KNOW LABS INC (KNW) stock?

KNOW LABS INC (KNW) has a profitability rating of 0 / 10.


What is the expected EPS growth for KNOW LABS INC (KNW) stock?

The Earnings per Share (EPS) of KNOW LABS INC (KNW) is expected to grow by 25% in the next year.